Mail-Order Pharmacy Dispensing of Mifepristone for Medication Abortion After In-Person Screening.

ABSTRACT:

Importance

Before 2021, the US Food and Drug Administration required mifepristone to be dispensed in person, limiting access to medication abortion.

Objective

To estimate the effectiveness, acceptability, and feasibility of dispensing mifepristone for medication abortion using a mail-order pharmacy.

Design, setting, and participants

This prospective cohort study was conducted from January 2020 to May 2022 and included 11 clinics in 7 states (5 abortion clinics and 6 primary care sites, 4 of which were new to abortion provision). Eligible participants were seeking medication abortion at 63 or fewer days' gestation, spoke English or Spanish, were age 15 years or older, and were willing to take misoprostol buccally. After assessing eligibility for medication abortion thr

SUBMITTER: Grossman D 

PROVIDER: S-EPMC11091818 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature